Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Herbal capsule may slow brain vessel damage in hypertension patients

NCT ID NCT07271732

First seen Jan 11, 2026 · Last updated May 22, 2026 · Updated 21 times

Summary

This study tests whether Songling Xuemaikang capsules can help control cerebral small vessel disease (CSVD), a condition where tiny blood vessels in the brain get damaged over time, often linked to high blood pressure. Researchers will enroll 90 adults aged 55-75 with high blood pressure and signs of CSVD on MRI. Half will get the herbal capsule, half a placebo, and they will be followed for one year to see changes in brain scans and thinking abilities.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HYPERTENSION are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Dongzhimen Hospital, Beijing University of Chinese Medicine

    Beijing, Beijing Municipality, 100700, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.